Dr Richard Kim speaks to ecancer at the ASCO Direct Highlights 2022 Miami Symposium about some of the new research into colorectal malignancies that was presented at this year's ASCO.

He first describes a trial that used immunotherapy in early locally advanced colorectal cancer demonstrating a clinical response of 100%.

Dr Kim also details studies investigating the use of EGFR inhibitors and a trial that looked into the predictive nature of tumour DNA.